NO20030021L - Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV - Google Patents

Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV

Info

Publication number
NO20030021L
NO20030021L NO20030021A NO20030021A NO20030021L NO 20030021 L NO20030021 L NO 20030021L NO 20030021 A NO20030021 A NO 20030021A NO 20030021 A NO20030021 A NO 20030021A NO 20030021 L NO20030021 L NO 20030021L
Authority
NO
Norway
Prior art keywords
dpp
inhibitors
heterocyclic compounds
enzyme dpp
compounds
Prior art date
Application number
NO20030021A
Other languages
English (en)
Other versions
NO20030021D0 (no
Inventor
Anders Bendtz Kanstrup
Lise Brown Christiansen
Jane Marie Lundbeck
Christian K Sams
Marit Kristiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2001/000467 external-priority patent/WO2002002560A2/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20030021D0 publication Critical patent/NO20030021D0/no
Publication of NO20030021L publication Critical patent/NO20030021L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse vedrører terapeutisk aktive og selektive inhibitorer for enzymet DPP-IV, farmasøytiske preparater Som omfatter forbindelsene, og anvendelsen av slike forbindelser til fremstillingen av medikamenter for behandling av sykdommer som er forbundet med proteiner som er gjenstand for inaktivering ved hjelp av DPP- IV, slik som sukkersyke av type 2 og fedme, samt fremgangsmåter for behandling av sykdommer som er forbundet med proteiner som er gjenstand for inaktivering ved hjelp av DPP-IV, slik som sukkersyke av type 2 og fedme.
NO20030021A 2000-07-04 2003-01-03 Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV NO20030021L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001040 2000-07-04
PCT/DK2001/000467 WO2002002560A2 (en) 2000-07-04 2001-07-04 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)

Publications (2)

Publication Number Publication Date
NO20030021D0 NO20030021D0 (no) 2003-01-03
NO20030021L true NO20030021L (no) 2003-03-03

Family

ID=8159598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030021A NO20030021L (no) 2000-07-04 2003-01-03 Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV

Country Status (13)

Country Link
EP (1) EP1561752A1 (no)
KR (1) KR20030014394A (no)
CN (1) CN1440288A (no)
AT (1) ATE299024T1 (no)
BR (1) BR0112123A (no)
CA (1) CA2411864A1 (no)
CZ (1) CZ200319A3 (no)
DE (1) DE60111849T2 (no)
ES (1) ES2244634T3 (no)
IL (1) IL153182A0 (no)
NO (1) NO20030021L (no)
RU (1) RU2003103103A (no)
ZA (1) ZA200209714B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102134229B (zh) * 2004-03-15 2020-08-04 武田药品工业株式会社 二肽基肽酶抑制剂
WO2006012395A2 (en) * 2004-07-23 2006-02-02 Susan Marie Royalty Peptidase inhibitors
CN102276627B (zh) * 2010-04-29 2013-07-31 山东轩竹医药科技有限公司 吡啶并杂环衍生物
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
CN103509023B (zh) * 2012-06-20 2014-08-27 成都苑东药业有限公司 黄嘌呤衍生物
MY189912A (en) 2013-03-15 2022-03-21 Hydra Biosciences Llc Substituted xanthines and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205815A1 (de) * 1972-02-08 1973-08-16 Hoechst Ag Piperazinderivate und verfahren zu ihrer herstellung
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
IL153182A0 (en) 2003-06-24
ES2244634T3 (es) 2005-12-16
KR20030014394A (ko) 2003-02-17
CN1440288A (zh) 2003-09-03
ZA200209714B (en) 2003-08-19
CA2411864A1 (en) 2002-01-10
BR0112123A (pt) 2003-05-06
ATE299024T1 (de) 2005-07-15
DE60111849T2 (de) 2006-06-08
EP1561752A1 (en) 2005-08-10
NO20030021D0 (no) 2003-01-03
CZ200319A3 (cs) 2003-05-14
DE60111849D1 (de) 2005-08-11
RU2003103103A (ru) 2004-08-20

Similar Documents

Publication Publication Date Title
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
WO2004033455A3 (en) Hemisuccinate salts of heterocyclic dpp-iv inhibitors
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
WO2003024965A3 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
ECSP055783A (es) Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
BR0009167A (pt) Inibidores de enzima impdh
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ECSP055732A (es) Inhibidores de la beta-amino heterocíclico dipeptidil peptidasa para el tratamiento o prevención de diabetes
ATE408601T1 (de) Fredericamycin-derivate
NO2007010I1 (no) Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DE60330485D1 (de) Zur behandlung von diabetes
GB0222495D0 (en) Compounds
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
MY138708A (en) Biaryloxymethylarenecarboxylic acids
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
ATE384058T1 (de) Thiazolderivate
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
AU2003260436A1 (en) Pyrimidine compounds
NO20030021L (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV
WO2004056306A3 (de) Verwendung von l-dopa, seiner derivate und diese verbindungen enthaltender arzneimittel zur prophylaxe psychotischer erkrankungen
WO2002023784A3 (en) Cysteine protease inhibitors